ANDA 74729, held by Cosette Pharms Nc. Tolmetin Sodium.
As of Nov 16, 2026, ANDA 74729 (Tolmetin Sodium), held by Cosette Pharms Nc, was first approved by FDA on Feb 27, 1997, with 7 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Feb 27, 1997 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Tolmetin SodiumEQ 600MG BASE · tablet;oral | Tolmetin Sodium | Discontinued |
| Nov 21, 2024 | Supplement 12Labeling · Standard review | Approved | None posted |
| Apr 28, 2021 | Supplement 11Labeling · Standard review | Approved | None posted |
| May 9, 2016 | Supplement 10Labeling · Standard review | Approved | None posted |
| Dec 2, 1999 | Supplement 8Manufacturing | Approved | None posted |
| Dec 2, 1999 | Supplement 9Manufacturing | Approved | None posted |
| Feb 12, 1999 | Supplement 1Manufacturing | Approved | None posted |
| Feb 12, 1999 | Supplement 2Manufacturing | Approved | None posted |
| Feb 27, 1997 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters